This inventor holds 8 USPTO granted patents and 2 published patent applications and 5 EPO patents. Top assignee: Liposcience, Inc.. Active years: 2016-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2023
Title: Innovator Thomas M O'Connell: Advancements in Diabetes Risk Evaluation and NMR Quantification
Introduction
Thomas M O'Connell is a distinguished inventor based in Chapel Hill, NC, known for his significant contributions to the fields of biosensing and diabetes risk evaluation. With a remarkable portfolio of 8 patents, O'Connell's innovations stand to enhance the understanding and management of various medical conditions.
Latest Patents
Among his latest patents is the "NMR quantification of TMAO." This invention focuses on identifying a specific peak region in a proton NMR spectrum of an in vitro biosample to evaluate levels of trimethylamine-N-oxide (TMAO). The method applies to various biosamples, including human serum and urine, with defined normal biological ranges for both substances.
Another notable patent is for "Multi-parameter diabetes risk evaluations." This system utilizes advanced methods, systems, and circuits to assess a subject's risk of developing type 2 diabetes or having prediabetes. The innovation encompasses a mathematical model that stratifies risk among patients with similar glucose measurements, integrating NMR-derived measurements and selected lipoprotein components from the biosample.
Career Highlights
Thomas M O'Connell currently contributes his expertise at Liposcience, Inc., where he pioneers research in biosamples and their impact on health diagnostics. His work is instrumental in advancing methodologies that enhance patient care and risk prediction in diabetic conditions.
Collaborations
O'Connell has collaborated with respected colleagues such as James D Otvos and Dennis W Bennett, pooling their collective knowledge and skills to push the boundaries of current medical research and innovation. Their collective efforts aim to develop improved diagnostic tools that can directly influence public health positively.
Conclusion
In summary, Thomas M O'Connell's work is crucial in the intersection of innovative technology and healthcare, particularly in diabetes risk management and biosample analysis. His patents not only represent personal achievement but also signify contributions that can have a lasting impact on medical diagnostics and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile